RUSSELL PAUL BOWLER

Summary

Publications

  1. ncbi Surfactant protein D as a biomarker for chronic obstructive pulmonary disease
    Russell P Bowler
    Department of Medicine, National Jewish Health, Denver, CO, USA
    COPD 9:651-3. 2012
  2. ncbi beta2-agonists promote host defense against bacterial infection in primary human bronchial epithelial cells
    Claire A Gross
    Department of Medicine, National Jewish Health, 1400 Jackson Street, Denver, Colorado 80206, USA
    BMC Pulm Med 10:30. 2010
  3. ncbi Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease
    Jayaji M Moré
    Department of Medicine, National Jewish Health, Denver, CO, USA
    BMC Pulm Med 10:53. 2010
  4. ncbi Alterations in the human lung proteome with lipopolysaccharide
    Russell P Bowler
    Department of Medicine, National Jewish Health, Denver, Colorado, USA
    BMC Pulm Med 9:20. 2009

Research Grants

  1. Metabolome and proteome profiles of emphysema and airway disease
    Russell Bowler; Fiscal Year: 2009
  2. Metabolome and proteome profiles of emphysema and airway disease
    RUSSELL PAUL BOWLER; Fiscal Year: 2010

Collaborators

  • Nichole Reisdorph
  • Edward Abraham
  • Claire A Gross
  • Jayaji M Moré
  • Dennis R Voelker
  • Hong Wei Chu
  • Andrew R Weinberger
  • Rebecca M Green
  • Lori J Silveira
  • Michael G Edwards
  • Edward D Chan
  • Christina Schnell

Detail Information

Publications4

  1. ncbi Surfactant protein D as a biomarker for chronic obstructive pulmonary disease
    Russell P Bowler
    Department of Medicine, National Jewish Health, Denver, CO, USA
    COPD 9:651-3. 2012
    ..One such candidate is the lung specific protein surfactant protein D (SP-D). In this review, we discuss the evidence supporting SP-D as a COPD biomarker...
  2. ncbi beta2-agonists promote host defense against bacterial infection in primary human bronchial epithelial cells
    Claire A Gross
    Department of Medicine, National Jewish Health, 1400 Jackson Street, Denver, Colorado 80206, USA
    BMC Pulm Med 10:30. 2010
    ..beta2-agonists are mainstay of COPD and asthma therapy, but whether beta2-agonists directly affect airway epithelial host defense functions is unclear...
  3. ncbi Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease
    Jayaji M Moré
    Department of Medicine, National Jewish Health, Denver, CO, USA
    BMC Pulm Med 10:53. 2010
    ..We hypothesized that COPD patients would have reduced bronchoalveolar lavage (BAL) fluid SP-D levels compared to healthy smoking and non-smoking controls...
  4. ncbi Alterations in the human lung proteome with lipopolysaccharide
    Russell P Bowler
    Department of Medicine, National Jewish Health, Denver, Colorado, USA
    BMC Pulm Med 9:20. 2009
    ....

Research Grants2

  1. Metabolome and proteome profiles of emphysema and airway disease
    Russell Bowler; Fiscal Year: 2009
    ..The study will also study how genes control protein expression in the blood, thereby increasing our understanding on how genetic background determines a person's response to cigarette smoke. (End of Abstract) ..
  2. Metabolome and proteome profiles of emphysema and airway disease
    RUSSELL PAUL BOWLER; Fiscal Year: 2010
    ..The study will also study how genes control protein expression in the blood, thereby increasing our understanding on how genetic background determines a person's response to cigarette smoke. (End of Abstract) ..